Samsara Bio Capital, LLC Instil Bio, Inc. Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.6 - $0.91 $1.07 Million - $1.63 Million	1,788,280 New	1,788,280 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $857,450 - $2.27 Million	-203,670 Reduced 10.22%	1,788,280 $8.26 Million
Q4 2021 Feb 14, 2022	SELL	$15.37 - $22.5 $2.36 Million - $3.45 Million	-153,445 Reduced 7.15%	1,991,950 $34.1 Million
Q2 2021 Aug 17, 2021	BUY	$15.31 - $24.63 $9.05 Million - $14.6 Million	591,370 Added 38.05%	2,145,395 $41.4 Million
Q1 2021 May 18, 2021	BUY	$24.23 - $27.06 $37.7 Million - $42.1 Million	1,554,025 New	1,554,025 $39 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.